We are live on ! Find out more
TRIL

Trillium Therapeutics Inc.
TRIL

Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

137 hedge funds and large institutions have $818M invested in Trillium Therapeutics Inc. in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 45 increasing their positions, 38 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $9.33M | Put options by funds: $4.01M

57% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 21

18% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 38

10% more funds holding

Funds holding: 125 → 137 (+12)

1% more capital invested

Capital invested by funds: $812M → $818M (+$6.42M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
137
Holders Change
+12
Holders Change %
+9.6%
% of All Funds
2.38%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
33
Increased
45
Reduced
38
Closed
21
Calls
$9.33M
Puts
$4.01M
Net Calls
+$5.32M
Net Calls Change
-$821K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$52.8M
2
EAM
Eventide Asset Management
Massachusetts
+$17.4M
3
PAMU
Pictet Asset Management (UK)
United Kingdom
+$12.8M
4
State Street
State Street
Massachusetts
+$12.4M
5
WP
Woodline Partners
California
+$7.82M

Top Sellers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
-$19.2M
2
CC
Commodore Capital
New York
-$8.55M
3
SFM
Sphera Funds Management
Israel
-$7.2M
4
ACP
Acuta Capital Partners
California
-$7.11M
5
GTC
Ghost Tree Capital
New York
-$6.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
76
D.E. Shaw & Co
New York
$553K +$537K +57,036 New
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$552K -$761K -80,819 -59%
Commonwealth Equity Services
78
Commonwealth Equity Services
Massachusetts
$538K +$225K +23,930 +76%
GC
79
Guggenheim Capital
Illinois
$520K +$23.1K +2,455 +5%
Truist Financial
80
Truist Financial
North Carolina
$502K -$37.6K -4,000 -7%
Group One Trading
81
Group One Trading
Illinois
$460K -$203K -21,579 -31%
Osaic Holdings
82
Osaic Holdings
Arizona
$439K +$71.2K +7,570 +20%
ACM
83
Alethea Capital Management
Washington
$414K -$1.28K -136 -0.3%
Parallax Volatility Advisers
84
Parallax Volatility Advisers
California
$397K +$385K +40,943 New
BCM
85
Bourgeon Capital Management
Connecticut
$390K +$94.1K +10,000 +33%
VOYA Investment Management
86
VOYA Investment Management
Georgia
$376K +$365K +38,780 New
MIM
87
MetLife Investment Management
New Jersey
$374K +$363K +38,562 New
JP Morgan Chase
88
JP Morgan Chase
New York
$364K +$353K +37,555 New
RJA
89
Raymond James & Associates
Florida
$348K +$13.4K +1,424 +4%
B
90
Bailard
California
$301K +$292K +31,000 New
Mackenzie Financial
91
Mackenzie Financial
Ontario, Canada
$293K +$83.5K +8,870 +41%
AA
92
AlphaCentric Advisors
Puerto Rico
$291K +$282K +30,000 New
MLICM
93
Metropolitan Life Insurance Company (MetLife)
New York
$286K +$278K +29,523 New
QSS
94
Quantitative Systematic Strategies
Florida
$280K -$283K -30,118 -51%
ProShare Advisors
95
ProShare Advisors
Maryland
$246K +$239K +25,377 New
PPA
96
Parametric Portfolio Associates
Washington
$234K +$227K +24,154 New
GIA
97
Gladstone Institutional Advisory
Florida
$228K +$951 +101 +0.4%
Russell Investments Group
98
Russell Investments Group
United Kingdom
$226K -$169K -17,953 -43%
SO
99
STRS Ohio
Ohio
$220K +$214K +22,700 New
BFM
100
Boothbay Fund Management
New York
$205K +$199K +21,123 New
2 3
4
5 6

TRIL Hedge Fund Activity: Q2 2021 in Review

137 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Trillium Therapeutics Inc. (TRIL) for Q2 2021, worth a combined $818M — up 0.79% from $812M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new TRIL positions and 21 closed out — a net gain of 12 holders — while 45 added to existing stakes and 38 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $52.8M. The largest seller was VR Adviser, cutting an estimated $19.2M.

  • 137 institutional investors held Trillium Therapeutics Inc. (TRIL) as of Q2 2021, up from 125 in Q1 2021.
  • Funds reported $818M of Trillium Therapeutics Inc. stock for Q2 2021, up 0.79% quarter-over-quarter.
  • 33 funds opened new Trillium Therapeutics Inc. positions in Q2 2021 and 21 closed out, a net change of +12 holders.
  • The largest Trillium Therapeutics Inc. buyer in Q2 2021 was BlackRock, an estimated $52.8M added.
  • The largest Trillium Therapeutics Inc. seller in Q2 2021 was VR Adviser, an estimated $19.2M sold.

Based on aggregated 13F filings for Q2 2021.